BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
Evolva India Pvt. Ltd.
IICT, Uppal Rd.
Hyderabad 500 007
India
Phone: +91 93 4673 8534
PRINCIPAL INVESTORS: APIDC-VC
Aravis
Astellas Venture Capital LLC
Danish Growth Fund
Danish Innovation Investment (Dansk Innovationsinvestering)
Novartis Venture Fund
Symbion Capital
BUSINESS STRATEGY: Fundamentally improve the logistics and success rates of small molecule
therapeutic discovery, development and manufacturing through the
application of advanced evolutionary technologies, while sharing in the value
generated by these improvements, and the molecules that result, through
selective partnering, as well as the development of the Company's own
compound pipeline
AGREEMENTS: Name Products Content of Agreement Date
AnalytiCon generation and
research alliance 7/05
Discovery GmbH optimization of nuclear
receptor agonists and
related compounds
RESEARCH & DEVELOPMENT: Compounds for the treatment of cancer and diabetes, as well as antiinfectives
Watchmaker® technology platform
F. Hoffmann-La Roche Ltd.
Grenzacherstrasse 124
Basel CH-4070, Switzerland
Phone: +41 61-688-1111; Fax: +41 61-691-9391
Web: www.roche.com
E-mail: info@roche.com
KEY PERSONNEL: Dr. Franz B. Humer; Chairman and CEO
Dr. Erich Hunziker; CFO
Prof. Dr. Jonathan K.C. Knowles; Head, Research
William M. Burns; CEO, Pharmaceuticals Division
Dr Severin Schwan; CEO, Diagnostics Division
EMPLOYEES: 68,218 employees
HISTORY: Founded F. Hoffmann-La Roche & Co. in 1896 (Ltd. Since 1919)
Roche Holdings Inc. incorporated in Delaware in 1987
Scientists at Basel Institute for Immunology (Roche-sponsored) awarded
Nobel Prizes in 1984 and 1987
Founded Roche Holding Ltd. In 1989
Sold Medi-Physics in 1990
Acquired 60% equity in Genentech for $2.1b, with an option to acquire the
remaining interest until June 1999 (9/90)
Sold plant-protection business to Ciba-Geigy Ltd. (9/90)
Acquired worldwide PCR rights (1991)
Roche Biomedical Laboratories merged with National Health Laboratories to
become the Laboratory Corporation of America (1994)
Acquired Syntex Corp. for $5.3b (10/94) and renamed it Roche Bioscience
(see separate entry)
Sold the Syntex animal health products business to American Home
Products Corp. (7/95)
Copyright ©2006 AHC Media ® 159